OLEPTRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oleptro, and when can generic versions of Oleptro launch?
Oleptro is a drug marketed by Angelini Pharma and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has seventy-eight patent family members in thirty countries.
The generic ingredient in OLEPTRO is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oleptro
A generic version of OLEPTRO was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.
Summary for OLEPTRO
International Patents: | 78 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 8 |
Patent Applications: | 5,159 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OLEPTRO |
DailyMed Link: | OLEPTRO at DailyMed |
Recent Clinical Trials for OLEPTRO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Louis Stokes VA Medical Center | Phase 1 |
VA Connecticut Healthcare System | Phase 4 |
Algorithme Pharma Inc | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for OLEPTRO
Paragraph IV (Patent) Challenges for OLEPTRO
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OLEPTRO | Extended-release Tablets | trazodone hydrochloride | 150 mg and 300 mg | 022411 | 1 | 2010-10-18 |
US Patents and Regulatory Information for OLEPTRO
OLEPTRO is protected by two US patents.
Patents protecting OLEPTRO
Trazodone composition for once a day administration
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING DEPRESSION
Trazodone and trazodone hydrochloride in purified form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OLEPTRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OLEPTRO
See the table below for patents covering OLEPTRO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2001271481 | ⤷ Try a Trial | |
Brazil | 0112140 | comprimido de liberaÇço controlada, processo para a fabricaÇço, em um meio aquoso, de um excipiente de liberaÇço controlada e amido reticulado de elevado teor de amilose. | ⤷ Try a Trial |
Brazil | PI0615860 | composição farmacêutica de liberação prolongada, forma de dosagem sólida de liberação prolongada, e, método | ⤷ Try a Trial |
Israel | 203294 | טראזודון וטראזודון הידרוכלוריד בצורה טהורה (Trazodone and trazodone hydrochloride in purified form) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |